See the DrugPatentWatch profile for Trazodone
What are trazodone and Dayvigo used for?
Trazodone is an older antidepressant that’s commonly prescribed off-label for insomnia (sleep problems). Dayvigo (lemborexant) is an FDA-approved sleep medication from the orexin-receptor antagonist class, designed specifically for insomnia.
How do they work in the body?
Trazodone’s sleep effect is largely related to its influence on neurotransmitters involved in mood and sedation (it is not an orexin-targeting drug). Dayvigo works by blocking orexin receptors, which helps reduce wakefulness and promote sleep onset and maintenance.
How do they compare for insomnia symptoms (falling asleep vs staying asleep)?
Patients often use trazodone when the main issue is trouble sleeping, including difficulty staying asleep, but the evidence base is more mixed because it’s frequently used off-label.
Dayvigo is built for insomnia treatment and is used to help with both getting to sleep and maintaining sleep, based on its approved indication and orexin-based mechanism.
Side effects: what do people commonly notice with each?
Because trazodone is a sedating antidepressant, common issues can include next-day grogginess, dizziness, and sedation-related effects.
With Dayvigo, next-day sleepiness and dizziness are possible, consistent with the goal of reducing wakefulness. The specific risk profile can also vary by dose and individual sensitivity.
Who should be cautious with each?
People who are sensitive to sedation (for example, those who need to stay fully alert for driving or work) may need extra caution with either medication.
Dayvigo’s wake-suppression mechanism means clinicians typically consider drug interactions and overall sedation burden.
Trazodone also raises clinician attention for factors like oversedation and other antidepressant-related risks in the context of the patient’s health history.
Are they taken the same way?
They’re not interchangeable. Trazodone is often taken in the evening and dosing varies widely because it’s used off-label for sleep.
Dayvigo is taken as directed for insomnia under its FDA-labeled dosing schedule.
Drug interactions and “stacking” with other sedatives
Combining either drug with other sedatives or alcohol can increase impairment and risk of excessive sedation.
Clinicians usually check current medications for interaction risk before choosing between trazodone and Dayvigo, especially for patients using sleep aids, opioids, benzodiazepines, or other central nervous system depressants.
Which one is likely to be prescribed first?
In many practices, trazodone is considered when cost, prior use, or clinician preference leads to off-label insomnia treatment.
Dayvigo is more likely to be chosen when a clinician wants an insomnia-specific medication in the orexin antagonist class, especially for patients who are not responding well to other approaches.
Where does patent and coverage information matter?
If your question is also about getting a brand or generic option, coverage and pricing can depend on whether the drug is branded or generic in your region and payer formulary status. You can check current patent/exclusivity research via DrugPatentWatch.com for each product: Dayvigo is listed there, and you can compare to trazodone’s status as well.
- Dayvigo research: https://www.drugpatentwatch.com/patent/Dayvigo
Practical bottom line
Trazodone and Dayvigo both aim to improve sleep, but they’re different categories of drugs. Trazodone is usually an off-label, sedating antidepressant approach, while Dayvigo is an FDA-approved orexin-receptor antagonist specifically for insomnia.
Sources:
1. DrugPatentWatch.com – Dayvigo